Literature DB >> 25663496

Significant association between IL-32 gene polymorphisms and susceptibility to endometrial cancer in Chinese Han women.

Xiuzhang Yu1, Bin Zhou, Zhu Zhang, Qianqian Gao, Yanyun Wang, Yaping Song, Yan Pu, Yue Chen, Ruiqi Duan, Lin Zhang, Mingrong Xi.   

Abstract

Interleukin-32 (IL-32), a pro-inflammatory chemokine, has been reported to be involved in inflammatory, infectious diseases and even cancers. This study aimed to investigate whether two genetic variants (rs28372698 and rs12934561) of IL-32 were associated with susceptibility to endometrial cancer (EC) in Chinese Han women by a hospital-based study with 272 EC patients and 337 healthy controls. Our results showed that the frequencies of TT genotype (P = 0.012, OR = 2.37, 95 % CI = 1.32-4.28) and T allele (P = 0.026, OR = 1.320, 95 % CI = 1.036-1.681) of rs28372698 in EC patients were significantly higher than controls. Clinical analyses indicated the TT genotype frequency was relevant to high clinical stage and cervical invasion. Furthermore, the frequencies of CC genotype (P = 0.0077, OR = 1.62, 95 % CI = 1.05-2.50) and C allele (P = 0.043, OR = 1.269, 95 % CI = 1.011-1.592) of rs12934561 were also significantly higher in EC patients than controls. Stratification analyses revealed that CC genotype was more frequent in endometrioid adenocarcinoma or EC without parametrial invasion. This study demonstrates that IL-32 gene polymorphisms are significantly associated with increased EC susceptibility in Chinese Han women.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25663496     DOI: 10.1007/s13277-015-3186-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  37 in total

Review 1.  The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling.

Authors:  M Karin; M Delhase
Journal:  Semin Immunol       Date:  2000-02       Impact factor: 11.130

Review 2.  Inflammation and endometrial cancer: a hypothesis.

Authors:  Francesmary Modugno; Roberta B Ness; Chu Chen; Noel S Weiss
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-12       Impact factor: 4.254

3.  Interleukin-32: a cytokine and inducer of TNFalpha.

Authors:  Soo-Hyun Kim; Sun-Young Han; Tania Azam; Do-Young Yoon; Charles A Dinarello
Journal:  Immunity       Date:  2005-01       Impact factor: 31.745

4.  A promoter polymorphism in human interleukin-32 modulates its expression and influences the risk and the outcome of epithelial cell-derived thyroid carcinoma.

Authors:  Theo S Plantinga; Irene Costantini; Bas Heinhuis; Angelique Huijbers; George Semango; Benno Kusters; Mihai G Netea; Ad R M M Hermus; Jan W A Smit; Charles A Dinarello; Leo A B Joosten; Romana T Netea-Maier
Journal:  Carcinogenesis       Date:  2013-03-13       Impact factor: 4.944

Review 5.  Endometrial cancer.

Authors:  Joel I Sorosky
Journal:  Obstet Gynecol       Date:  2008-02       Impact factor: 7.661

6.  Expression of IL-32 modulates NF-κB and p38 MAP kinase pathways in human esophageal cancer.

Authors:  Nasser Ghaly Yousif; Fadhil G Al-Amran; Najah Hadi; Jillen Lee; Jonthan Adrienne
Journal:  Cytokine       Date:  2012-10-26       Impact factor: 3.861

7.  Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis.

Authors:  Jan-Hendrik Egberts; Vera Cloosters; Andreas Noack; Bodo Schniewind; Lutz Thon; Stefanie Klose; Bastian Kettler; Corinna von Forstner; Christian Kneitz; Jürgen Tepel; Dieter Adam; Harald Wajant; Holger Kalthoff; Anna Trauzold
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

Review 8.  Novel insights into the biology of interleukin-32.

Authors:  Leo A B Joosten; Bas Heinhuis; Mihai G Netea; Charles A Dinarello
Journal:  Cell Mol Life Sci       Date:  2013-03-06       Impact factor: 9.261

9.  IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.

Authors:  J H Oh; M-C Cho; J-H Kim; S Y Lee; H J Kim; E S Park; J O Ban; J-W Kang; D-H Lee; J-H Shim; S B Han; D C Moon; Y H Park; D-Y Yu; J-M Kim; S H Kim; D-Y Yoon; J T Hong
Journal:  Oncogene       Date:  2011-03-21       Impact factor: 9.867

10.  Endogenous IL-32 controls cytokine and HIV-1 production.

Authors:  Marcel F Nold; Claudia A Nold-Petry; Gregory B Pott; Jarod A Zepp; Milene T Saavedra; Soo-Hyun Kim; Charles A Dinarello
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.426

View more
  8 in total

1.  Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer.

Authors:  Kayhan Erturk; Didem Tastekin; Murat Serilmez; Elif Bilgin; Hamza Ugur Bozbey; Sezai Vatansever
Journal:  Tumour Biol       Date:  2015-07-29

2.  Influence of IL-1R2 polymorphisms on endometrial cancer susceptibility in the Chinese Han population.

Authors:  Jiamin Wu; Wenjie Zhang; Junhong Cai; Sizhe Huang; Fanglin Niu; Ying Zhang; Shan Bao; Tianbo Jin
Journal:  Mol Genet Genomic Med       Date:  2019-03-20       Impact factor: 2.183

3.  Effects of IL-32 polymorphisms and IL-32 levels on the susceptibility and severity of coronary artery disease.

Authors:  Susu Jin; Xiujing Liu; Yingying Wang; Jian Yu; Minghua Jiang
Journal:  J Clin Lab Anal       Date:  2021-11-19       Impact factor: 2.352

Review 4.  A Paradoxical Effect of Interleukin-32 Isoforms on Cancer.

Authors:  Saerok Shim; Siyoung Lee; Yasmin Hisham; Sinae Kim; Tam T Nguyen; Afeisha S Taitt; Jihyeong Hwang; Hyunjhung Jhun; Ho-Young Park; Youngmin Lee; Su Cheong Yeom; Sang-Yeob Kim; Yong-Gil Kim; Soohyun Kim
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

5.  lncRNA NBAT1 Inhibits Cell Metastasis and Promotes Apoptosis in Endometrial Cancer by Sponging miR-21-5p to Regulate PTEN.

Authors:  Chunhua Tian; Jing Su; Zhao Ma; Yang Wu; Hongyun Ma
Journal:  Comput Math Methods Med       Date:  2022-07-20       Impact factor: 2.809

6.  Association of Plasma IL-32 Levels and Gene Polymorphisms with Systemic Lupus Erythematosus in Chinese Han Population.

Authors:  Yanyun Wang; Bin Zhou; Yi Zhao; Xiuzhang Yu; Yi Liu; Lin Zhang
Journal:  Dis Markers       Date:  2016-02-29       Impact factor: 3.434

7.  Clinical Significance of Serum Interleukin-31 and Interleukin-33 Levels in Patients of Endometrial Cancer: A Case Control Study.

Authors:  Xi Zeng; Zhu Zhang; Qian-Qian Gao; Yan-Yun Wang; Xiu-Zhang Yu; Bin Zhou; Ming-Rong Xi
Journal:  Dis Markers       Date:  2016-05-31       Impact factor: 3.434

8.  Associations between Interleukin-32 Gene Polymorphisms rs12934561 and rs28372698 and Susceptibilities to Bladder Cancer and the Prognosis in Chinese Han Population.

Authors:  Jie Yang; Zhongyu Jian; Pengfei Shen; Yunjin Bai; Yin Tang; Jia Wang
Journal:  Dis Markers       Date:  2020-11-05       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.